Concepedia
Statistics
Publications
48
Citations
2K
H-Index
24
Active since
2009
Affiliations
Istituti di Ricovero e Cura a Carattere Scientifico(Current)
Istituto Oncologico Veneto
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Fondazione IRCCS Istituto Nazionale dei Tumori
University of Parma
Mimma Rizzo is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, urology, and oncology.
Top concepts
MedicineOncologyUrologyCancer TherapyPharmacotherapyPharmacologyRadiation OncologyPathologyImmunologyImmunotherapy
Publications per year
2009–2024
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations
Oncology, Hepatology, Medicine +10
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni et al. · Annals of Oncology · 2009 · 204 citations · Full text
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Giuseppe Di Lorenzo, Giacomo Cartenì, Riccardo Autorino et al. · Journal of Clinical Oncology · 2009 · 134 citations · Full text
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
Sergio Bracarda, Roberto Iacovelli, Luca Boni et al. · Annals of Oncology · 2015 · 105 citations · Full text
Urology, Oncology, Genitourinary Cancer +5
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors
Matteo Santoni, Alessandro Conti, Stefano Partelli et al. · Annals of Surgical Oncology · 2014 · 90 citations
Surgical Resection Does, Urology, Surgical Oncology +7
1–5 of 48